glp-1 and liver Why are agonists being used to treat patients with nonalcoholic fatty disease? Glucagon‐like peptide‐1 receptor agonists (GLP‐1

This highlights the need for further research to establish the safety and efficacy of semaglutide in patients with a history of psychiatric conditions

Diabetologia 48(5):856861

The company replies to 98% of negative reviews, typically within a week

Robert Weisman can be reached at [email protected]

It also decreases A and phosphorylated tau aggregates in the hippocampus [86]

The researchers analyzed thousands of electronic medical records of older adults with both diabetes and cancer and found that those who were taking GLP-1s had lower all-cause mortality than did those who were taking another type of diabetes medication, dipeptidyl peptidase 4 inhibitors (DPP-4i)